Sinusitis decisions — 2025

The Board dismissed the claims for service connection for a respiratory disability, hyperlipidemia (high cholesterol), and sinusitis due to lack of evidence supporting current disabilities.

The Board denied the veteran's claim for service connection for sinusitis as there was no evidence of a current diagnosis during or near the period on appeal.

The Board remands the Veteran's claim for a compensable rating for sinusitis due to an error by the AOJ in satisfying a regulatory duty regarding notice of the right to a hearing.

The Board denied service connection for various conditions, including sinusitis, chronic fatigue syndrome (CFS), and headaches, among others. Sleep apnea was granted.

The Board remands the claims for a compensable disability rating for allergic rhinitis and sinusitis to obtain an examination that assesses the severity of these conditions without the ameliorative effects of medication.

The Board granted service connection for chronic fatigue syndrome, cephalgia/chronic headaches, allergic rhinitis, sinusitis, lumbosacral strain, thoracic segmental dysfunction, and lumbar spine disc syndrome. A 30 percent rating was assigned for cervical strain.

The Board denied service connection for allergic rhinitis, erectile dysfunction (ED), and bilateral flat feet as the evidence did not support a medical nexus between these conditions and the Veteran's period of active duty.

The Board granted service connection for chronic sinusitis under the PACT Act and a 30 percent disability rating for right shoulder rotator cuff tendonitis, impingement syndrome, and glenohumeral joint osteoarthritis beginning April 22, 2022.

The veteran withdrew his appeal for all service connection and initial rating issues, thus the Board has no jurisdiction to review these appeals.

The Board granted a 10 percent rating for allergic rhinitis, resolving any doubts in the Veteran's favor.

The Board denied service connection for chronic sinusitis and an initial compensable rating for allergic rhinitis.

The Board denied an initial compensable rating for chronic sinusitis as the evidence did not support a 10 percent rating under the applicable criteria.

The Veteran withdrew all pending appeals, as he is now rated 100 percent from November 22, 2022.

The Board granted service connection for osteoradionecrosis, bilateral eye disability (including cataracts and glaucoma), and bilateral hearing loss. It also granted a 10% rating for hypertension, a 50% rating for chronic sinusitis with rhinitis, and a 100% rating for lymphedema. The Board denied compensable ratings for the residuals of squamous cell carcinoma of the left tonsil and neck.

The Board granted an effective date of July 11, 2023, for the grant of service connection for PTSD, migraines, a bilateral shoulder disability, a low back disability, and bilateral knee disability.

The Board remands the matter for a medical nexus opinion regarding the Veteran's respiratory epithelial adenomatoid hamartoma and its potential relation to exposure at Camp Lejeune.

The Board granted service connection for unspecified depressive disorder and other specified anxiety disorder, but denied or remanded the claims for service connection for a recurrent temporomandibular joint (TMJ) disability, prostatitis, erectile dysfunction, left elbow disability, esophageal disability to include GERD, gastrointestinal disability to include IBS, headache disability, right shoulder disability, heart disability, bilateral foot disability, and compensable ratings for hemorrhoids and allergic rhinitis.

The Board remands the claims for a higher rating for GERD, service connection for diabetes, glaucoma, sinusitis, and obstructive sleep apnea due to inadequate medical opinions regarding their relationship to the Veteran's service, including his exposure to contaminated water at Camp Lejeune.

The Board denied an initial higher rating in excess of 30 percent for chronic sinusitis and a higher rating in excess of 30 percent for allergic rhinitis, as the evidence did not support a higher rating under the applicable criteria. The claim for an initial higher rating in excess of 40 percent for CFS was remanded due to a duty to assist error.

The Board granted an initial 10 percent rating for sinusitis, but denied a compensable rating for allergic rhinitis.